# Phio Pharmaceuticals Corp.: Form 8-K, filed Jul 26, 2023

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: 8-K
- Filed: 2023-07-26
- Accepted by EDGAR: Jul 26, 2023, 16:30 ET
- Period: 2023-07-20
- Accession: 0001683168-23-005094
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000168316823005094/phio_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000168316823005094/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000168316823005094/phio_8k.htm

Filed Jul 26, 2023.
Source: SEC EDGAR, the filing index for accession 0001683168-23-005094. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
